Aurdan Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.7M Sell
18,680
-4,866
-21% -$444K 0.43% 34
2026
Q1
$2.42M Sell
23,546
-827
-3% -$93.4K 0.73% 27
2025
Q4
$3.05M Buy
24,373
+247
+1% +$31.5K 0.94% 25
2025
Q3
$3.23M Sell
24,126
-12,938
-35% -$1.7M 1.03% 25
2025
Q2
$5.04M Sell
37,064
-925
-2% -$122K 1.72% 13
2025
Q1
$5.04M Sell
37,989
-9,895
-21% -$1.26M 1.9% 14
2024
Q4
$5.42M Buy
+47,884
New +$5.53M 2.08% 14

Other funds holding ABT

Aurdan Capital Management's ABT Position: Q2 2026 in Review

Aurdan Capital Management reduced its Abbott (ABT) stake by 21% in Q2 2026, selling an estimated $444K and leaving 18,680 shares worth $1.7M. The position accounts for 0.43% of the portfolio, ranked #34.

Aurdan Capital Management first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.42M in Q4 2024. 1,387 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Aurdan Capital Management held 18,680 shares of Abbott worth $1.7M as of Q2 2026.
  • Aurdan Capital Management sold 4,866 Abbott shares in Q2 2026, an estimated $444K.
  • Abbott made up 0.43% of Aurdan Capital Management's portfolio in Q2 2026, its #34 holding.
  • Aurdan Capital Management first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Aurdan Capital Management's Abbott position peaked at $5.42M in Q4 2024.
  • 1,387 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Aurdan Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.